BR0307436A - Procedimento para detectar a predisposição de uma doença cardiovascular - Google Patents

Procedimento para detectar a predisposição de uma doença cardiovascular

Info

Publication number
BR0307436A
BR0307436A BR0307436-6A BR0307436A BR0307436A BR 0307436 A BR0307436 A BR 0307436A BR 0307436 A BR0307436 A BR 0307436A BR 0307436 A BR0307436 A BR 0307436A
Authority
BR
Brazil
Prior art keywords
predisposition
cardiovascular disease
procedure
detect
chromosome
Prior art date
Application number
BR0307436-6A
Other languages
English (en)
Inventor
Jordi Fontcuberta Boj
Jose Manuel Soria Fernandez
Original Assignee
Fundacio Privada I Inst De Rec
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fundacio Privada I Inst De Rec filed Critical Fundacio Privada I Inst De Rec
Publication of BR0307436A publication Critical patent/BR0307436A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

"PROCEDIMENTO PARA DETECTAR A PREDISPOSIçãO DE UMA DOENçA CARDIOVASCULAR". Inclui os seguintes passos (1) a obtenção de uma amostra biológica humana e (ii)e, a identificação, no material genético da mencionada amostra, a presença de pelo menos uma variante alélica dentro do loco do cromossomo 5, limitada pelos marcadores D5S400 e D5S408, cuja presença indica predisposição para doença cardiovascular. No mencionado processo, é usada uma amostra biológica capaz de incluir no mínimo uma variante alélica dentro do loco do cromossomo 5 limitada pelos marcadores D5S400 e D5S408 de maneira de determinar a predisposição para doenças cardiovasculares as quais manifestam complicações trombóticas. O processo permite detectar a predisposição para doença cardiovascular humana, de maneira de planejar uma adequada estratégia terapêutica preventiva.
BR0307436-6A 2002-01-31 2003-01-30 Procedimento para detectar a predisposição de uma doença cardiovascular BR0307436A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200200308A ES2222775B1 (es) 2002-01-31 2002-01-31 Procedimiento para la deteccion de una predisposicion a una enfermedad cardiovascular.
PCT/IB2003/000315 WO2003064690A2 (en) 2002-01-31 2003-01-30 Process for detecting predisposition to a cardiovascular disease

Publications (1)

Publication Number Publication Date
BR0307436A true BR0307436A (pt) 2005-03-29

Family

ID=27635991

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0307436-6A BR0307436A (pt) 2002-01-31 2003-01-30 Procedimento para detectar a predisposição de uma doença cardiovascular

Country Status (13)

Country Link
US (1) US20070105095A1 (pt)
EP (1) EP1499744A2 (pt)
JP (1) JP2005515791A (pt)
KR (1) KR20040102001A (pt)
CN (1) CN1738907A (pt)
AU (1) AU2003201505B2 (pt)
BR (1) BR0307436A (pt)
CA (1) CA2474724A1 (pt)
ES (1) ES2222775B1 (pt)
MX (1) MXPA04007441A (pt)
NZ (1) NZ534341A (pt)
RU (1) RU2323440C2 (pt)
WO (1) WO2003064690A2 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0362531B1 (en) 1988-09-01 1999-11-10 Bayer Corporation A human rhinovirus receptor protein that inhibits virus infectivity
US10352947B2 (en) * 2012-09-12 2019-07-16 Berg Llc Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease
CN109879213B (zh) * 2019-03-30 2020-09-04 安徽永捷力智能装备有限公司 一种能自行上下货车的电动叉车

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683194A (en) * 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences

Also Published As

Publication number Publication date
WO2003064690A2 (en) 2003-08-07
NZ534341A (en) 2008-04-30
ES2222775B1 (es) 2006-12-16
ES2222775A1 (es) 2005-02-01
CN1738907A (zh) 2006-02-22
RU2323440C2 (ru) 2008-04-27
JP2005515791A (ja) 2005-06-02
RU2004123610A (ru) 2005-06-10
AU2003201505B2 (en) 2007-06-28
US20070105095A1 (en) 2007-05-10
EP1499744A2 (en) 2005-01-26
WO2003064690A3 (en) 2003-12-24
MXPA04007441A (es) 2005-04-19
CA2474724A1 (en) 2003-08-07
KR20040102001A (ko) 2004-12-03

Similar Documents

Publication Publication Date Title
Gupta et al. A systematic review of biomarkers of gingival crevicular fluid: Their predictive role in diagnosis of periodontal disease status
NO20052955L (no) Behandling av Huntingtons sykdom med EPA
DE602004022150D1 (de) Verfahren und kit zum nachweis des frühstadiums einer nierentubuluszellenverletzung
WO2008069975A3 (en) Methods of using f-spondin as a biomarker for cartilage degenerative conditions
WO2004046729A3 (en) Bodily fluid markers of tissue hypoxia
EP1474510A4 (en) COMPOSITIONS AND METHODS FOR DETECTION, DIAGNOSIS AND THERAPY OF HEMATOLOGICAL MALIGNITIES
ATE532070T1 (de) Entzündungsmarker zum nachweis und zur prävention von diabetes mellitus
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
BR9915732A (pt) Geração de anticorpos usando-se vacinação de polinucleotìdeo em espécie de ave
WO2006025028A3 (en) Novel classification method of blood cells and tailor-made therapy and prevention based thereupon
WO2003087760A3 (en) Methods for detecting bcr-abl signaling activity in tissues using phospho- specific antibodies
BR9906926A (pt) Composições e métodos para tratamento de células tendo dna de minuto duplo
BRPI0511127A (pt) prouroguanilina e análogos sintéticos ou produtos da clivagem proteolìtica dela derivados, como agentes terapêuticos e de diagnósticos para doenças que envolvem a homeostasia de sal e/ou de lìquidos
DE69019375D1 (de) Verfahren zur detektion von knochen- und anderen bindegewebeerkrankungen bei menschen und tieren.
PL1889920T3 (pl) Sposób identyfikacji związków do terapii antynowotworowej in vitro
EP1796675A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT OF EYE DISEASES
EP1451552A4 (en) FOR DETECTING DISORDERS OF BREAST SUITABLE REAGENTS AND METHODS
AU2003250938A1 (en) Method for determination of thymidine kinase 1 activity and the use thereof
EP1883427A4 (en) COMPOSITIONS AND METHODS FOR THE INVESTIGATION AND TREATMENT OF INFLAMMATORY DISEASES AND DISEASES
BRPI0418022A (pt) biomarcadores para sensibilidade de doenças proliferativas a inibidores de mtor
WO2006089219A3 (en) Neoepitope detection of disease using protein arrays
WO2005108599A3 (en) Compositions and methods for treatment of protein misfolding diseases
ATE422500T1 (de) Neue chelidonin-derivate, verfahren zu ihrer herstellung und ihre verwendung zur herstellung von pharmazeutischen wirkstoffen
Mendez-Lopez et al. Spatial short-term memory in rats: effects of learning trials on metabolic activity of limbic structures
MXPA04007441A (es) Procedimiento para la deteccion de una predisposicion a una enfermedad cardiovascular.

Legal Events

Date Code Title Description
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]